1/7/08 - Stonefly Communications Honored at 2007 Global Awards
Professional Assignment Includes 14 Brands

Columbus, Ohio – January 07, 2008 – Stonefly Communications Group, an inVentiv Health Company (NASDAQ: VTIV), was honored at the 2007 Global Awards. The Global Awards competition honors outstanding work in healthcare communications and advertising. The field of entry for 2007 included submissions from over 36 countries.

Stonefly, a customer–centric marketing, advertising and communications agency, was recognized with a Finalist Certificate for its work on the Novo Nordisk GlucaGen HypoKit, "GlucaGen HypoKit Sales Force T–Shirts: Shirt 1/Shirt 2", in the category Professional: Brand Reminders.

About Stonefly Communications Group

Stonefly Communications Group is a customer–centric marketing, advertising and communications agency dedicated to redefining success for its clients around the world. With a promise to continually innovate, Stonefly's client advisors and creative champions develop actionable strategies that engage audiences with bold strategic, tactical and creative solutions. See how Stonefly can help you venture out SM by visiting www.stoneflygroup.com

About inVentiv Health

inVentiv Health (NASDAQ: VTIV) is the leading provider of commercialization and complementary services to the healthcare industry globally. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its four core business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial and inVentiv Patient Outcomes. inVentiv Health's client roster is comprised of more than 275 leading pharmaceutical, biotech, life sciences and healthcare payor companies, including the top 20 global pharmaceutical manufacturers. For more information, visit www.inventivhealth.com.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health, Inc. with the Securities and Exchange Commission for further discussion of these and other factors.